Case report: Glioblastoma multiforme (1998)

Record number: 
86
MPHO Type: 
Estimated frequency: 
- Most recent risk assessment for astrocytoma WHO grades 3 or 4 and glioblastoma WHO grade 4 (Council of Europe, 2025): Spontaneous extraneural metastases of grade 3 astrocytomas and grade 4 glioblastomas are rare, but such metastases have been observed, and seem to occur more frequently when associated with prior surgical treatment and/or ventriculo-peritoneal drainage or chemo-/radiotherapy. Potential donors with WHO grade 3 astrocytomas can be accepted as organ donors. Transmission risk is considered low to intermediate for tumours without any risk factors. Potential donors with glioblastoma IDH-wildtype or astrocytoma IDH-mutant are considered intermediate risk for transmission, depending on different national recommendations, which are expected to be adjusted with increasing evidence. The transmission risk is increased in all cases with previous interventions such as tumour resection, ventriculo-peritoneal/-atrial drainage and/or cranial chemo-/radiotherapy.
Time to detection: 
5 months
Alerting signals, symptoms, evidence of occurrence: 
Rapid clinical deterioration resulting in death, five months after liver transplantation. Necropsy shows multiple intrahepatic, adrenal gland, lymph node, and leptomeningeal metastases of a gliomatous tumor.
Demonstration of imputability or root cause: 
Condition known in the donor. Frontal lobe glioma removed 4 months before death with local recurrence and death following a second surgery. Two kidneys and liver were transplanted. No evidence of malignant disease in the two kidney recipients 2 months after transplantation. So only one recipient affected. Histopathological examination of the primary and recurrent brain tumour and of all metastatic lesions showed the classic features of glioblastoma multiforme (GBM). The primary GBM was the only lesion to express glial fibrillary acidic protein (GFAP). Loss of GFAP expression during disease progression coincided with the less differentiated histological appearance of the locally recurrent and metastatic lesions and is directly associated with glioma dissemination. Microsatellite DNA fingerprinting revealed identical allele patterns in all brain tumour and metastatic lesions, thus identifying all metastases as donor related. In addition, DNA sequencing of the p53 tumour suppressor gene showed a C→T transition changing aminoacids from histidine to tyrosine at codon 179 in all lesions. Alternatively spliced variants of the CD44 cell adhesion molecule expressed by both the recurrent brain tumour and its metastatic lesions were linked with the unusual metastatic phenotype of a GBM and, in addition, support the previously proposed metastasis model.
Imputability grade: 
3 Definite/Certain/Proven
Groups audience: 
Suggest new keywords: 
Neoplasia
Case Report
Deceased donor
Liver transplant
Kidney transplant
Histologic analysis
Immunohistochemistry
DNA typing
Central nervous system
Glioblastoma multiforme
Astrocytoma/glioblastoma multiform E. (WHO grade 4)
Patient death
Suggest references: 
aaa
Expert comments for publication: 
Lliver recipient developed tumor; both kidney recipients from same donor alive without tumor at 52 month followup.